MST continus 5 mg tablets

*
Pharmacy Only: Prescription

Updated on 28 November 2024

File name

ie-spc-mst-continus-5mg-clean.pdf

Reasons for updating

  • Change to section 4.9 - Overdose
  • Change to section 10 - Date of revision of the text

Legal category:Product subject to medical prescription which may not be renewed (A)

Free text change information supplied by the pharmaceutical company

4.9      Overdose

 Toxic leukoencephalopathy has been observed with morphine overdose.

10.      DATE OF (PARTIAL) REVISION OF THE TEXT

 27th November 2024


Updated on 28 November 2024

File name

ie-pl-mst-continus-clean.pdf

Reasons for updating

  • Change to section 2 - excipient warnings
  • Change to section 3 - overdose, missed or forgotten doses
  • Change to section 6 - what the product contains
  • Change to section 6 - what the product looks like and pack contents
  • Change to section 6 - date of revision
  • Removal of one or more presentations from joint PIL

Free text change information supplied by the pharmaceutical company

Updates are done in below sections:

2.         What you need to know before you take MST Continus tablets

MST Continus tablets contain lactose and Sunset Yellow (E110)

The 5 mg, 10 mg, 15 mg, and 30 mg and 60 mg tablets contain lactose which is a form of sugar. If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking these tablets.

The 30 mg and 60 mg tablets contain Sunset yellow (E110) which may cause allergic reactions.

3.         How to take MST Continus tablets

If you take more MST Continus tablets than you should

Call your doctor or hospital straight away as you may need emergency treatment in hospital. People who have taken an overdose may feel very sleepy, sick, dizzy, get a brain disorder (known as toxic leukoencephalopathy) or get pneumonia from inhaling vomit or foreign matter (symptoms may include breathlessness, cough and fever). People who have taken an overdose may also have breathing difficulties leading to unconsciousness, or even death. When seeking medical attention make sure that you take this leaflet and any remaining tablets with you to show to the doctor.

6.        Contents of the pack and other information

What MST Continus tablets contain

The active ingredient is morphine sulfate.  Each tablet contains 5 mg, 10 mg, 15 mg, 30 mg, 60 mg or 100 mg of morphine sulfate.

The tablets also contain the following colourants:

10 mg – Iron oxide (E172)

15 mg - Iron oxide (E172), brilliant blue (E133), quinoline yellow (E104) and indigo carmine (E132)

30 mg – Erythrosine (E127), indigo carmine (E132) and sunset yellow (E110)

60 mg - Erythrosine (E127), quinoline yellow (E104) and sunset yellow (E110)

100 mg - Iron oxide (E172) and indigo carmine (E132)

What MST Continus tablets look like and the contents of the pack

MST Continus tablets are marked with NAPP on one side and the strength (e.g. 5 mg, 10 mg, etc) on the other.  

The tablets are film-coated in the following colours: 5 mg - white, 10 mg – golden brown, 15 mg - green, 30 mg – purple, 60 mg - orange, 100 mg – grey.

This leaflet was last revised in March November 2024.

Updated on 06 November 2024

File name

Patient Leaflet-PIL-IE-MST continus-clean.pdf

Reasons for updating

  • Change to section 2 - excipient warnings
  • Change to section 6 - what the product contains
  • Change to section 6 - what the product looks like and pack contents
  • Change to section 6 - date of revision
  • Removal of one or more presentations from joint PIL

Free text change information supplied by the pharmaceutical company

Removal of 60 mg strength from common PIL due to withdrawal application.

Updated on 28 May 2024

File name

IE_MST continus_PIL (Clean)-v4[IE Reporting].pdf

Reasons for updating

  • Change to section 2 - what you need to know - contraindications
  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 2 - interactions with other medicines, food or drink
  • Change to section 3 - how to take/use
  • Change to section 4 - possible side effects
  • Change to section 4 - how to report a side effect
  • Change to section 6 - date of revision

Updated on 28 May 2024

File name

IE_MST continus_5mg_SmPC (Clean).pdf

Reasons for updating

  • Change to section 4.2 - Posology and method of administration
  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
  • Change to section 4.8 - Undesirable effects

Legal category:Product subject to medical prescription which may not be renewed (A)

Updated on 29 March 2023

File name

mst continus-smpc-5mg-clean.pdf

Reasons for updating

  • New SPC for new product

Legal category:Product subject to medical prescription which may not be renewed (A)

Free text change information supplied by the pharmaceutical company

IE MAH Address Change

Updated on 29 March 2023

File name

mst continus-pil-clean.pdf

Reasons for updating

  • New PIL for new product

Free text change information supplied by the pharmaceutical company

IE MAH Address Change